Several CNS disorders associated with specific antibodies to ion channels, receptors, and other synaptic proteins have been recognised over the past 10 years, and can be often successfully treated with immunotherapies. Antibodies to components of voltage-gated potassium channel complexes (VGKCs), NMDA receptors (NMDARs), AMPA receptors (AMPARs), GABA type B receptors (GABA(B)Rs), and glycine receptors (GlyRs) can be identified in patients and are associated with various clinical presentations...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Autoantibodies associated with diseases of the CNS: new developments and future challenges.
If you are the owner of this record, you can report an update to it here: Report update to this record